Moderna and Pfizer and BioNTech have been neck and neck in the race for regulatory approval in the US.
The US Food and Drug Administration authorized Pfizer’s COVID-19 vaccine for emergency useone week before Moderna’sin December 2020.
ThemRNA vaccineswork by teaching our cells how to create an immune response to a virus.
